COVID-19 inflammation and implications in drug delivery.
Biomimetics
Bioresponsive
Drug delivery
Inflammation
Mesenchymal stem cells
Nanodecoys
Nanomedicine
SARS-CoV-2
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
10
03
2022
accepted:
15
04
2022
pubmed:
27
4
2022
medline:
22
6
2022
entrez:
26
4
2022
Statut:
ppublish
Résumé
Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed in COVID-19 severe cases are narrowly associated with the disease's poor prognosis. Therefore, targeting the inflammatory pathways seems to be a rational therapeutic strategy against COVID-19. Many anti-inflammatory agents have been proposed; however, most of them suffer from poor bioavailability, instability, short half-life, and undesirable biodistribution resulting in off-target effects. From a pharmaceutical standpoint, the implication of COVID-19 inflammation can be exploited as a therapeutic target and/or a targeting strategy against the pandemic. First, the drug delivery systems can be harnessed to improve the properties of anti-inflammatory agents and deliver them safely and efficiently to their therapeutic targets. Second, the drug carriers can be tailored to develop smart delivery systems able to respond to the microenvironmental stimuli to release the anti-COVID-19 therapeutics in a selective and specific manner. More interestingly, some biosystems can simultaneously repress the hyperinflammation due to their inherent anti-inflammatory potency and endow their drug cargo with a selective delivery to the injured sites.
Identifiants
pubmed: 35469984
pii: S0168-3659(22)00223-1
doi: 10.1016/j.jconrel.2022.04.027
pmc: PMC9045711
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
260-274Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Références
Eur J Pharmacol. 2019 Jun 5;852:68-76
pubmed: 30682335
J Am Chem Soc. 2021 Oct 27;143(42):17615-17621
pubmed: 34647745
J Clin Med. 2020 Dec 12;9(12):
pubmed: 33322733
J Control Release. 2020 Nov 10;327:641-666
pubmed: 32911014
J Nanobiotechnology. 2021 Dec 13;19(1):417
pubmed: 34903236
Cells. 2021 Mar 07;10(3):
pubmed: 33799966
Stem Cell Res Ther. 2021 Oct 30;12(1):561
pubmed: 34717769
Acta Pharm Sin B. 2021 Apr;11(4):941-960
pubmed: 33996408
Acta Pharmacol Sin. 2022 Dec;43(12):3021-3033
pubmed: 35058587
Cytokine Growth Factor Rev. 2022 Feb;63:10-22
pubmed: 34580015
Matter. 2020 Jul 1;3(1):18-20
pubmed: 32835219
Clin Immunol. 2021 May;226:108712
pubmed: 33684527
Signal Transduct Target Ther. 2021 Jun 7;6(1):225
pubmed: 34099630
J Nanobiotechnology. 2021 Jun 10;19(1):173
pubmed: 34112203
AAPS J. 2018 Feb 26;20(2):37
pubmed: 29484558
Rev Med Virol. 2022 Mar;32(2):e2281
pubmed: 34363275
Sci China Life Sci. 2020 Aug;63(8):1254-1256
pubmed: 32410090
Cancer Res. 2015 Jun 15;75(12):2520-9
pubmed: 25883092
Adv Mater. 2018 Apr;30(15):e1702749
pubmed: 29512198
Clin Chim Acta. 2020 Oct;509:280-287
pubmed: 32531256
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27141-27147
pubmed: 33024017
Sci Rep. 2021 Apr 15;11(1):8289
pubmed: 33859336
Front Immunol. 2020 Aug 18;11:1979
pubmed: 32973803
Pharmaceutics. 2021 Jan 06;13(1):
pubmed: 33419176
Int J Biol Sci. 2017 Jul 6;13(7):828-834
pubmed: 28808416
Interface Focus. 2021 Dec 10;12(1):20210006
pubmed: 34956607
Theranostics. 2018 Jan 5;8(4):1131-1145
pubmed: 29464004
ACS Nano. 2019 Feb 26;13(2):1272-1283
pubmed: 30673266
Int Immunopharmacol. 2020 Dec;89(Pt B):107088
pubmed: 33129099
Expert Rev Anti Infect Ther. 2021 Feb;19(2):147-163
pubmed: 32853038
Clin Immunol. 2022 Apr;237:108958
pubmed: 35218966
Adv Sci (Weinh). 2019 May 22;6(15):1900605
pubmed: 31406672
Nanoscale. 2016 Apr 7;8(13):6981-5
pubmed: 26975904
Front Pharmacol. 2021 Jul 09;12:707205
pubmed: 34305613
Front Cell Dev Biol. 2021 Sep 20;9:734720
pubmed: 34616741
Nat Rev Immunol. 2020 Jul;20(7):397-398
pubmed: 32457522
Chin Med J (Engl). 2020 May 5;133(9):1051-1056
pubmed: 32149769
Adv Drug Deliv Rev. 2020;157:161-178
pubmed: 32697950
Drug Deliv. 2021 Dec;28(1):1109-1119
pubmed: 34121563
Sci Adv. 2021 Nov 26;7(48):eabl6432
pubmed: 34818042
ACS Nano. 2020 Mar 24;14(3):2569-2574
pubmed: 32129977
Stem Cell Rev Rep. 2021 Feb;17(1):176-192
pubmed: 33432484
Clin Transl Sci. 2021 Jan;14(1):132-136
pubmed: 33135382
Front Bioeng Biotechnol. 2020 Jun 17;8:627
pubmed: 32626700
Vaccines (Basel). 2021 Sep 04;9(9):
pubmed: 34579226
Adv Mater. 2018 Jun;30(23):e1706759
pubmed: 29582476
J Control Release. 2020 Apr 10;320:304-313
pubmed: 32004586
Biomaterials. 2017 Aug;135:62-73
pubmed: 28494264
Acta Biomater. 2020 Jan 15;102:416-426
pubmed: 31760223
Adv Exp Med Biol. 2019;1201:93-108
pubmed: 31898783
Acta Pharm Sin B. 2021 Aug;11(8):2585-2604
pubmed: 34522599
CNS Neurosci Ther. 2020 Jun;26(6):603-615
pubmed: 32356605
J Transl Med. 2021 Apr 22;19(1):164
pubmed: 33888147
Nat Rev Immunol. 2020 Sep;20(9):515-516
pubmed: 32728221
Rheumatol Ther. 2022 Apr;9(2):379-389
pubmed: 35107804
Biomater Sci. 2020 Jan 21;8(2):552-568
pubmed: 31769765
J Control Release. 2022 Jan;341:591-604
pubmed: 34896449
Nat Nanotechnol. 2021 Aug;16(8):942-951
pubmed: 34140674
Nat Mater. 2016 Sep;15(9):1037-46
pubmed: 27213956
ACS Appl Mater Interfaces. 2021 May 12;13(18):20995-21006
pubmed: 33930273
Stem Cells Dev. 2020 Jun 15;29(12):747-754
pubmed: 32380908
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
J Mater Chem B. 2018 Dec 7;6(45):7354-7365
pubmed: 31372220
Cells. 2021 Oct 25;10(11):
pubmed: 34831101
Mol Pharm. 2021 Jun 7;18(6):2105-2121
pubmed: 33945284
Nanomedicine (Lond). 2017 Nov;12(21):2677-2692
pubmed: 28965474
Eur J Pharm Biopharm. 2022 Mar;172:1-15
pubmed: 35074554
Acta Pharm Sin B. 2020 Aug;10(8):1521-1533
pubmed: 32963947
World J Radiol. 2020 Nov 28;12(11):247-260
pubmed: 33362916
J Nanobiotechnology. 2019 May 13;17(1):60
pubmed: 31084622
Matter. 2022 Jan 5;5(1):336-362
pubmed: 34693277
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211048026
pubmed: 34569339
ACS Nano. 2021 Apr 27;15(4):6326-6339
pubmed: 33724785
Stem Cell Res Ther. 2021 Aug 21;12(1):469
pubmed: 34419143
J Clin Med. 2021 Feb 11;10(4):
pubmed: 33670202
Regen Biomater. 2021 Jul 18;8(4):rbab033
pubmed: 34285811
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
Front Pharmacol. 2021 May 07;12:675287
pubmed: 34025433
Int J Clin Exp Pathol. 2021 Jul 15;14(7):831-844
pubmed: 34367415
Front Immunol. 2021 Oct 01;12:738697
pubmed: 34659231
Front Bioeng Biotechnol. 2022 Feb 04;9:797359
pubmed: 35186913
Acta Biomed. 2020 May 11;91(2):150-168
pubmed: 32420939
Nanoscale. 2019 Jul 28;11(28):13576-13586
pubmed: 31290914
Leukemia. 2021 Sep;35(9):2616-2620
pubmed: 33990684
Front Immunol. 2021 Jul 08;12:660632
pubmed: 34305892
J Control Release. 2020 Nov 10;327:546-570
pubmed: 32911013
Matter. 2020 Jul 1;3(1):287-301
pubmed: 32835220
Crit Care Med. 2020 Jul;48(7):e599-e610
pubmed: 32317602
Acta Pharm Sin B. 2018 Jan;8(1):23-33
pubmed: 29872620
Phytomedicine. 2019 Sep;62:152956
pubmed: 31132753
Clin Immunol. 2021 Oct;231:108828
pubmed: 34425240
Trends Pharmacol Sci. 2021 Feb;42(2):106-118
pubmed: 33342562
Front Pharmacol. 2020 May 08;11:612
pubmed: 32457616
Stem Cells Int. 2020 Sep 24;2020:8835986
pubmed: 33014070
Int J Med Sci. 2021 Jun 1;18(13):2849-2870
pubmed: 34220313
Iran J Basic Med Sci. 2019 Mar;22(3):282-289
pubmed: 31156789
Biomedicines. 2021 Dec 03;9(12):
pubmed: 34944639
Adv Mater. 2020 Oct;32(39):e2003368
pubmed: 32812291
Circ Res. 2020 Jan 3;126(1):25-37
pubmed: 31647755
J Control Release. 2021 Oct 10;338:813-836
pubmed: 34478750
Sci Rep. 2021 Jun 29;11(1):13464
pubmed: 34188167
Acta Biomater. 2021 Mar 15;123:354-363
pubmed: 33476827
Front Pharmacol. 2021 Nov 09;12:724525
pubmed: 34858170
Int J Mol Sci. 2021 Sep 08;22(18):
pubmed: 34575865
J Cell Physiol. 2021 Jul;236(7):5325-5338
pubmed: 33372280
Stem Cell Res Ther. 2020 Aug 14;11(1):356
pubmed: 32795359
Cytokine. 2021 Jul;143:155544
pubmed: 33926774
Nanomaterials (Basel). 2020 Nov 20;10(11):
pubmed: 33233748
Pharmaceutics. 2021 Oct 18;13(10):
pubmed: 34684017
FASEB J. 2021 Apr;35(4):e21441
pubmed: 33749902
Clin Rheumatol. 2020 Jul;39(7):2085-2094
pubmed: 32474885
Drug Deliv. 2021 Dec;28(1):2582-2593
pubmed: 34866533
Int J Pharm. 2019 Mar 25;559:271-279
pubmed: 30690130
Physiol Rev. 2020 Oct 1;100(4):1455-1466
pubmed: 32496872
Biomater Sci. 2020 Mar 17;8(6):1575-1579
pubmed: 32096499
Adv Sci (Weinh). 2018 Aug 16;5(10):1800781
pubmed: 30356945
Int J Nanomedicine. 2021 Nov 16;16:7663-7681
pubmed: 34815670
J Drug Target. 2020 Nov;28(9):873-881
pubmed: 32298153
J Control Release. 2020 Nov 10;327:70-87
pubmed: 32735878
Clin Immunol. 2020 Jun;215:108427
pubmed: 32325252
Front Pharmacol. 2021 Nov 22;12:732403
pubmed: 34880750
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Nature. 2020 Dec;588(7836):146-150
pubmed: 32726800
J Biomol Struct Dyn. 2021 Jun;39(9):3409-3418
pubmed: 32306836
Science. 2014 Aug 8;345(6197):679-84
pubmed: 25104388
Clin Transl Med. 2019 Sep 12;8(1):25
pubmed: 31512000
Am J Pathol. 2021 Jan;191(1):4-17
pubmed: 32919977
Mol Divers. 2022 Feb;26(1):629-645
pubmed: 33400086
J Pharm Pharm Sci. 2020;23:259-277
pubmed: 32735768
J Control Release. 2016 Feb 28;224:208-216
pubmed: 26778696
Postgrad Med J. 2021 May;97(1147):312-320
pubmed: 32978337
Signal Transduct Target Ther. 2021 Jul 7;6(1):255
pubmed: 34234112
Pharmaceutics. 2020 Dec 17;12(12):
pubmed: 33348630
Sci Adv. 2021 Jun 16;7(25):
pubmed: 34134990
Int Immunopharmacol. 2021 Jan;90:107171
pubmed: 33221168
Signal Transduct Target Ther. 2020 Sep 3;5(1):186
pubmed: 32883951
Biomedicines. 2021 Oct 01;9(10):
pubmed: 34680490
J Transl Med. 2021 May 31;19(1):234
pubmed: 34059065
Chem Phys Lipids. 2021 Jan;234:105009
pubmed: 33189639
Acta Pharm Sin B. 2022 Feb;12(2):600-620
pubmed: 34401226
Nanoscale. 2015 Mar 14;7(10):4291-305
pubmed: 25680099
Exp Ther Med. 2021 Sep;22(3):1011
pubmed: 34345293
Appl Clay Sci. 2022 Jan;216:106333
pubmed: 34776567
Cell Death Dis. 2020 Oct 15;11(10):863
pubmed: 33060560
Adv Sci (Weinh). 2021 Dec;8(24):e2102330
pubmed: 34693653
Inflamm Regen. 2020 Oct 1;40:37
pubmed: 33014208
J Control Release. 2021 Jan 10;329:445-453
pubmed: 33285103
Transl Res. 2021 Jun;232:37-48
pubmed: 33358868
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Eur J Immunol. 2021 Jul;51(7):1652-1659
pubmed: 33738806
Nano Today. 2021 Jun;38:101149
pubmed: 33846686
Bioact Mater. 2022 Feb 11;14:430-442
pubmed: 35415281
Adv Drug Deliv Rev. 2020;165-166:15-40
pubmed: 31816357
Front Immunol. 2020 Jun 23;11:1518
pubmed: 32655582
Front Chem. 2020 Sep 11;8:787
pubmed: 33062636
Biomaterials. 2021 Jan;267:120389
pubmed: 33130319
ACS Appl Mater Interfaces. 2019 May 8;11(18):16380-16390
pubmed: 30973702
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11488-11493
pubmed: 29073076
Acta Pharm Sin B. 2021 Aug;11(8):2096-2113
pubmed: 34522579
Stem Cell Rev Rep. 2021 Feb;17(1):33-43
pubmed: 32661867
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
J Immunother Cancer. 2021 May;9(5):
pubmed: 33986127
PeerJ. 2020 Sep 18;8:e9928
pubmed: 32999767
Adv Sci (Weinh). 2021 Mar 01;8(8):2002499
pubmed: 33898169
FASEB J. 2021 Apr;35(4):e21360
pubmed: 33749932
Curr Opin Biotechnol. 2019 Aug;58:81-91
pubmed: 30529814
Drug Deliv Transl Res. 2021 Aug;11(4):1475-1497
pubmed: 33860447
Front Mol Biosci. 2021 Jul 21;8:699929
pubmed: 34368228
ACS Nano. 2017 Mar 28;11(3):3262-3273
pubmed: 28264157
J Drug Deliv Sci Technol. 2021 Dec;66:102738
pubmed: 36568326
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Nat Rev Immunol. 2021 Nov;21(11):694-703
pubmed: 34373622
Int J Mol Sci. 2021 Nov 17;22(22):
pubmed: 34830303
Front Bioeng Biotechnol. 2020 Aug 19;8:906
pubmed: 32974295
Eur J Pharm Sci. 2017 Jan 1;96:115-128
pubmed: 27496050
Front Immunol. 2020 Nov 30;11:570993
pubmed: 33329533
Sci Adv. 2020 Jun 05;6(23):eaaz5466
pubmed: 32548259
Nano Lett. 2020 Jul 8;20(7):5570-5574
pubmed: 32551679
Trends Biotechnol. 2021 Jun;39(6):598-612
pubmed: 33160678
Nano Today. 2021 Feb;36:101031
pubmed: 33519948